Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ocular Surface Following Cataract Surgery in Ocular Graft-Versus-Host Disease: A Multicenter National Analysis.

Cornea·2026
Same author

Correction: Pickleball and Ball Sports-Related Ocular Trauma in the United States.

Eye (London, England)·2026
Same author

Oncolytic vesicular stomatitis virus modulates invadopodia morphology and inhibits invasive behaviors in Src-transformed fibroblasts.

Virology·2026
Same author

Academic stress among radiography students: Examining the impact of GPA and class level on student well-being and performance.

Journal of education and health promotion·2026
Same author

Salubrious effects of <i>Ficus carica</i> L. leaves extract in inflammation, diabetes, and obesity: An in-vitro, in-silico, and in-vivo study.

Food & nutrition research·2026
Same author

Trends and disparities in disseminated intravascular coagulation-related mortality among adults aged 25 and above in the U.S., 1999-2020: CDC WONDER insights.

Thrombosis journal·2026

Related Experiment Video

Updated: Apr 20, 2026

Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

10.4K

Treatment options for atypical optic neuritis.

Amina Malik, Maryam Ahmed, Karl Golnik1

  • 1University of Cincinnati, Cincinnati Eye Institute, Cincinnati, USA.

Indian Journal of Ophthalmology
|December 3, 2014
PubMed
Summary

Atypical optic neuritis (ON) presents differently from typical cases and requires prompt treatment. Early intervention with corticosteroids and immunosuppressants is crucial for preserving vision in these rare forms of optic nerve inflammation.

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.7K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.2K

Related Experiment Videos

Last Updated: Apr 20, 2026

Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

10.4K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.7K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.2K

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Optic neuritis (ON) involves optic nerve inflammation with diverse causes.
  • Typical ON in the US is often demyelinating and linked to multiple sclerosis.
  • Atypical ON has distinct clinical features, management, and prognoses compared to typical ON.

Purpose of the Study:

  • To delineate the clinical presentations of atypical optic neuritis.
  • To outline the treatment strategies for atypical ON.

Main Methods:

  • Literature review.
  • Analysis of a review article.

Main Results:

  • Identified atypical ON types: neuromyelitis optica, autoimmune optic neuropathy, chronic relapsing inflammatory optic neuropathy, idiopathic recurrent neuroretinitis, and systemic disease-associated optic neuropathy.
  • Atypical ON typically necessitates corticosteroid therapy.
  • Aggressive immunosuppression is frequently required for effective management.

Conclusions:

  • Atypical optic neuritis demands specific treatment interventions.
  • Unlike demyelinating ON, atypical forms require active treatment to prevent vision loss.